Healthcare provider profile · identity verified

Brian Kurtz, DO

Internal Medicine · CHICAGO, IL · NPI 1831469253

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1038	254
Amlodipine Besylate	Amlodipine Besylate	722	172
Albuterol Sulfate Hfa	Albuterol Sulfate	402	99
Lisinopril	Lisinopril	369	80
Hydrochlorothiazide	Hydrochlorothiazide	341	72
Gabapentin	Gabapentin	332	76
Furosemide	Furosemide	317	74
Omeprazole	Omeprazole	306	78
Metoprolol Succinate	Metoprolol Succinate	286	78
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	223	46
Rosuvastatin Calcium	Rosuvastatin Calcium	216	55
Jardiance	Empagliflozin	201	44
Tamsulosin Hcl	Tamsulosin Hcl	196	47
Duloxetine Hcl	Duloxetine Hcl	173	36
Montelukast Sodium	Montelukast Sodium	171	46
Levothyroxine Sodium	Levothyroxine Sodium	164	31
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	153	28
Famotidine	Famotidine	152	42
Losartan Potassium	Losartan Potassium	152	41
Sertraline Hcl	Sertraline Hcl	148	31
Metformin Hcl	Metformin Hcl	147	44
Potassium Chloride	Potassium Chloride	144	30
Mirtazapine	Mirtazapine	142	31
Valsartan	Valsartan	139	40
Carvedilol	Carvedilol	137	42
Spironolactone	Spironolactone	130	35
Pantoprazole Sodium	Pantoprazole Sodium	124	21
Eliquis	Apixaban	117	27
Ozempic	Semaglutide	117	25
Nifedipine Er	Nifedipine	116	24
Atenolol	Atenolol	98	18
Fluticasone Propionate	Fluticasone Propionate	96	35
Allopurinol	Allopurinol	93	22
Ibuprofen	Ibuprofen	90	29
Metoprolol Tartrate	Metoprolol Tartrate	89	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	88	23
Quetiapine Fumarate	Quetiapine Fumarate	83	18
Diclofenac Sodium	Diclofenac Sodium	81	34
Entresto	Sacubitril/Valsartan	76	22
Pravastatin Sodium	Pravastatin Sodium	75	12
Baclofen	Baclofen	74	18
Simvastatin	Simvastatin	68	19
Tramadol Hcl	Tramadol Hcl	67	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	16
Naproxen	Naproxen	59	19
Xarelto	Rivaroxaban	57	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	51	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	11
Warfarin Sodium	Warfarin Sodium	47	suppressed
Metformin Hcl Er	Metformin Hcl	46	11
Enalapril Maleate	Enalapril Maleate	44	suppressed
Novolog Flexpen	Insulin Aspart	44	suppressed
Finasteride	Finasteride	42	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	42	14
Donepezil Hcl	Donepezil Hcl	41	suppressed
Chlorthalidone	Chlorthalidone	40	12
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Trazodone Hcl	Trazodone Hcl	38	13
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Ammonium Lactate	Ammonium Lactate	34	18
Myrbetriq	Mirabegron	34	12
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Prednisone	Prednisone	33	28
Rybelsus	Semaglutide	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Meloxicam	Meloxicam	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	11
Verapamil Sr	Verapamil Hcl	31	suppressed
Levetiracetam	Levetiracetam	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Pregabalin	Pregabalin	28	suppressed
Brilinta	Ticagrelor	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Torsemide	Torsemide	27	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Latanoprost	Latanoprost	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	12
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Lidocaine	Lidocaine	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Azithromycin	Azithromycin	23	21
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Varenicline Tartrate	Varenicline Tartrate	22	11
Lovastatin	Lovastatin	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Ketoconazole	Ketoconazole	18	11
Topiramate	Topiramate	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Colchicine	Colchicine	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Glipizide	Glipizide	15	suppressed
Lumigan	Bimatoprost	15	suppressed
Nystatin	Nystatin	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Cyclosporine	Cyclosporine	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Travoprost	Travoprost	12	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error